Skip to main content
See every side of every news story
Published loading...Updated

India Inc to Bet over $20.5 Billion Across Key US Sectors in Major Investment Push

Pharmaceutical firms account for more than $19.1 billion of the total, with plans for U.S. manufacturing, research and new facilities, officials said.

  • On Wednesday, Indian companies announced a record $20.5 billion in investments into the United States at the 2026 SelectUSA Investment Summit in Maryland.
  • The pharmaceutical sector drives the significant share of investment, with over $19.1 billion planned for manufacturing and research, anchored by Sun Pharmaceutical Industries Ltd.'s $11.75 billion purchase of New Jersey-based Organon.
  • Additional commitments include $900 million from the Abdhudyay Group across five sites to create 1,500 American jobs, plus a $225-million facility modernization by JSW Steel in Ohio and Texas.
  • Ambassador Sergio Gor called the investments the "largest we've seen" on Tuesday, stating that under President Donald Trump, investment is flowing into the United States at record levels.
  • The investments support the goal of doubling US-India bilateral trade to $500 billion by 2030, aiming to balance trade ties after India's roughly $41 billion surplus last year.
Insights by Ground AI

18 Articles

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources lean Right
100% Right

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

Edex Live broke the news on Tuesday, May 5, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal